Avai Bio (AVAI) Operating Expenses (2018 - 2025)

Avai Bio has disclosed Operating Expenses across 8 years of filings, most recently posting $509774.0 for Q4 2025.

• Operating Expenses for Q4 2025 came in at $509774.0, up 18.86% year-over-year; the trailing twelve-month figure through Dec 2025 was $1.4 million (down 27.72% YoY), and the FY2025 annual result was $1.5 million, down 27.6% from the prior year.
• Operating Expenses came in at $509774.0 for Q4 2025 at Avai Bio, up from $394666.0 in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $1.0 million in Q4 2023 to a low of -$38446.0 in Q1 2025.
• The 5-year median for Operating Expenses is $257062.0 (2021), against an average of $302966.1.
• Across the five-year window, Operating Expenses surged 1939.34% in 2023 and plunged 112.67% in 2025, its largest moves.
• Avai Bio's Operating Expenses stood at $210692.0 in 2021, then sank by 76.4% to $49717.0 in 2022, then soared by 1939.34% to $1.0 million in 2023, then sank by 57.7% to $428898.0 in 2024, then advanced by 18.86% to $509774.0 in 2025.
• The last three Operating Expenses figures came in at $509774.0 (Q4 2025), $394666.0 (Q3 2025), and $487589.0 (Q2 2025), per Business Quant data.